Mood Disorder is a mental health condition characterized by persistent changes in one’s emotional state from day to day. While a person’s mood can fluctuate depending on various factors, a person with a Mood Disorder experiences abnormally intense and lasting episodes of either depression or mania that can last for weeks or even months. The most common Mood Disorder is Major Depressive Disorder (MDD), which is defined by persistent feelings of sadness, hopelessness and/or melancholy that has been present for at least two weeks and interferes with daily functioning. Other common symptoms of MDD include poor concentration, low self-esteem, irritability, fatigue, sleep disturbances, decreased appetite, and loss of interest in activities once enjoyed. Bipolar Disorder is another type of Mood Disorder and is marked by extreme swings in one’s feelings and behaviors over time. These swings can range from periods of intense depression to mania, which is characterized by excessive energy, grandiose thinking, racing thoughts, impulsive decisions, and emotions that are “off the charts.” These changes in mood can occur either on their own, or in relation to other symptoms, as they can also cause physical and cognitive changes. Mood Disorder is often treated with medications such as antidepressants or mood stabilizers. In addition to medications, therapy is a powerful tool in treating Mood Disorders. Cognitive Behavioral Therapy has been found to be particularly beneficial as it works to reduce symptoms and promote healthy thinking patterns and behaviors. The goal of therapy is to help an individual identify and understand the thoughts and behaviors that may be causing or exacerbating their symptoms, and then to develop and practice healthy coping mechanisms. Mood Disorders are serious mental health conditions that can have a profound impact on a person’s life. Early diagnosis and treatment are essential to facilitate recovery and enable the person to experience a full and satisfying life.
Title : Novel important cellular responses, signaling mechanisms and therapeutic options in vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : TBI updates in 2025
Jonathan Eskenazi, Cedars Sinai / UCLA, United States
Title : A case of vile vindictive primary CNS vasculitis
George Diaz, Memorial Healthcare Systems, United States
Title : Non-pharmacological strategies to counteract oxaliplatin toxicity: Protective effects of vagal nerve stimulation and resistance training on neuropathy, motor dysfunction, and muscle atrophy
Ricardo Aparecido Baptista Nucci, Hospital Sirio-Libanes, Brazil
Title : Synapticare: Integrating sleep data and tau biomarkers to assess depression severity
Medha Menon, John Foster Dulles HS, United States
Title : How have we eliminated infection: From the bone to brain?
Thomas J Webster, Interstellar Therapeutics, United States